4 posts
Originally from Brooklyn, Barbara Weiss, 70, lives on Long Island, N.Y., with Dennis, 73, her husband of nearly 50 years, who received a diagnosis of mild cognitive impairment in 2023 and early-stage Alzheimer’s disease in 2026.
A blood biomarker test for Alzheimer’s disease was approved by the Food and Drug Administration well over a year ago, in May 2025, but according to medical professionals and advocacy organizations like the Alzheimer’s Association, there is still a significant public knowledge gap.
During an initial screening or diagnostic appointment, it's okay to have questions. Here are some common terms that you have may have heard before, but it can't hurt to have expert Dr. Manisha Santosh Parulekar review the basics.
Health Nation asked Dr. Manisha Santosh Parulekar, M.D., questions about the Alzheimer’s biomarker screening test. Here's what to know.
